Oruka Therapeutics, Inc. (ORKA : NASDAQ)
Common Stock
$79.92
USD
+0.83 (1.05%)
Last updated: 2026-10-21
Follow ORKA
ORKA
Oruka Therapeutics, Inc.
WealthAwesomePerformance
1 Day
+1.05%
1 Week
+4.23%
1 Month
-14.41%
YTD
+12.75%
Key Statistics
Market Cap
$5.29B
52W High
$115.52
52W Low
$25.23
P/E Ratio
-
50 Day MA
$91.07
200 Day MA
$67.06
Beta
-0.11
Dividend Yield
-
Advertisement
Technical Indicators
Price vs 50-Day SMA
Price vs 200-Day SMA
Recent Price History
| Date | Open | High | Low | Close | Adj Close | Volume |
|---|---|---|---|---|---|---|
| 10/21/2026 | $79.97 | $81.75 | $79.48 | $79.92 | $79.92 | 953,373 |
| 10/20/2026 | $74.42 | $79.90 | $74.42 | $79.09 | $79.09 | 778,762 |
| 10/19/2026 | $72.40 | $76.35 | $72.30 | $74.48 | $74.48 | 812,460 |
| 10/16/2026 | $73.75 | $74.26 | $70.50 | $71.93 | $71.93 | 1,388,200 |
| 10/15/2026 | $75.53 | $77.89 | $73.15 | $73.87 | $73.87 | 1,222,100 |
| 10/14/2026 | $77.37 | $78.57 | $75.41 | $76.68 | $76.68 | 685,300 |
| 10/13/2026 | $79.47 | $80.19 | $78.18 | $78.19 | $78.19 | 490,798 |
| 10/12/2026 | $81.81 | $82.95 | $79.43 | $80.35 | $80.35 | 547,900 |
| 10/9/2026 | $77.24 | $82.24 | $77.00 | $82.11 | $82.11 | 1,206,700 |
| 10/8/2026 | $78.47 | $80.19 | $75.83 | $77.28 | $77.28 | 1,224,945 |
Analyst Price Targets
Based on 13 analysts covering ORKA · as of Oct 5, 2026
Wall Street analysts forecast ORKA stock price to rise 93.9% over the next 12 months.
Consensus
Strong Buy4.85 / 5.00
Avg. Target
US$155.00
+93.9% Upside
Current Price
US$79.92
Last close
Analyst Breakdown (13 analysts)
Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on ORKA's historical volatility
30-Day Vol
49.2%
Annualized
90-Day Vol
60.5%
Annualized
Trend (90d)
-50.0%
Annualized drift
90d Mean
US$66.85
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | US$75.30 | US$63.55 – US$89.22 |
| 60 trading days | US$70.95 | US$55.82 – US$90.19 |
| 90 trading days | US$66.85 | US$49.83 – US$89.68 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
About Oruka Therapeutics, Inc.
Oruka Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing novel monoclonal antibody therapeutics for psoriasis (PsO), and other inflammatory and immunology (I&I) indications. Its lead products include ORKA-001 that targets p19 subunit of interleukin-23, which is in phase 2a trial for the treatment of PsO; and ORKA-002 that targets interleukin-17A and interleukin-17F, which is in phase 2 trial for the treatment of PsO, psoriatic arthritis, and other conditions. The company also develops ORKA-003 for targeting an undisclosed pathway; and ORKA-021, a sequential combination regimen of ORKA-002 and ORKA-001. Oruka Therapeutics, Inc. is headquartered in Menlo Park, California.
Financials
- Revenue (TTM)
- $0
- EBITDA
- $-154.94M
- Profit Margin
- 0.00%
- ROE (TTM)
- -18.23%
- EPS (Diluted)
- -2.04
- Book Value
- 18.20
Classification
- Sector
- Health Care
- Industry
- Biotechnology
- Group
- Pharmaceuticals, Biotechnology & Life Sciences
7 stocks to buy and hold forever
Blue-chip dividend stocks for long-term wealth building.
Get the FREE ReportExplore More
Advertisement
Common Questions About ORKA.US
Market movers
Recent NASDAQ movers
Top 1-day gainers — updated from our Canadian movers feed.
| Ticker | Name | Price | 1D |
|---|---|---|---|
| POM | POMDOCTOR LIMITED American Depositary Shares | $3.01 | +352.77% |
| MIMI | Mint Incorporation Limited Class A Ordinary Shares | $1.09 | +118.80% |
| SHFS | SHF Holdings Inc | $0.15 | +71.52% |
| LESLQ | Leslie's, Inc. | $0.07 | +63.06% |
| XHLD | TEN Holdings, Inc. Common Stock | $0.91 | +52.46% |
| WHLR | Wheeler Real Estate Investment Trust, Inc. | $0.53 | +47.22% |
| SPHL | Springview Holdings Ltd Class A Ordinary Shares | $3.54 | +45.68% |
| SVRN | OceanPal Inc. | $36.76 | +41.49% |
ORKA.US news timeline
1 article covering ORKA.US, most recent first
Latest